Implementation of Pharmacogenomics in Molecular Tumor Boards

Beate Jahn (ORCID: 0000-0002-6764-6362)

European Partnerships: PerMed

Disciplines

Health Sciences (30%); Computer Sciences (20%); Clinical Medicine (25%); Medical Biotechnology (25%)

Keywords

  • PGx diagnostics,
  • Molecular Tumor Boards,
  • Health Technology Assessment,
  • Cancer Therapy,
  • Benefit-Harm Analysis
Research institution(s)
International project participants
  • Birgit Geoerger - France, project partner
  • Markus Wartenberg - Germany, project partner
  • Stefan Fröhling - Germany, project partner
  • Volker Lauschke - Sweden, project partner